Notice: This company has been marked as potentially delisted and may not be actively trading. OTCMKTS:AVMXY AVITA MED LTD/S (AVMXY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis Get AVITA MED LTD/S alerts: Email Address About AVITA MED LTD/S Stock (OTCMKTS:AVMXY) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Get AVITA MED LTD/S alerts:Sign Up Key Stats Today's Range$7.89▼$7.8950-Day Range$7.89▼$7.8952-Week Range$1.06▼$8.58VolumeN/AAverage Volume183,275 shsMarket Capitalization$651.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAvita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.Read More… War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Receive AVMXY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA MED LTD/S and its competitors with MarketBeat's FREE daily newsletter. Email Address AVMXY Stock News HeadlinesAvita Medical Maintains Buy Rating Amid Strong Quarterly Performance and Positive Growth OutlookAugust 9, 2024 | markets.businessinsider.comCantor Fitzgerald Keeps Their Buy Rating on Avita Medical (RCEL)August 9, 2024 | markets.businessinsider.comWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.September 20, 2024 | Porter & Company (Ad)Avita Medical is about to announce its earnings — here's what to expectAugust 8, 2024 | markets.businessinsider.comRCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q1 2024May 13, 2024 | msn.comAVITA Medical GAAP EPS of -$0.73 misses by $0.24, revenue of $11.1M misses by $0.07MMay 13, 2024 | msn.comThree nurses receive DAISY Award at Avita Health SystemMay 10, 2024 | msn.comHogy Medical Co LtdApril 23, 2024 | morningstar.comSee More Headlines Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:AVMXY CUSIPN/A CIKN/A Webwww.avitamedical.com Phone661-367-9170FaxN/AEmployees55Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio5.50 Quick Ratio5.33 Sales & Book Value Annual Sales$5.51 million Price / Sales118.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.26 per share Price / Book30.35Miscellaneous Outstanding Shares82,620,000Free FloatN/AMarket Cap$651.87 million OptionableNot Optionable Beta1.28 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report This page (OTCMKTS:AVMXY) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA MED LTD/S Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA MED LTD/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.